Doctors Gene-Edit Patient's Liver to Make Less Cholesterol
A team of researchers from US biotech company Verve Therapeutics have injected a gene-editing serum into a live patient's liver with the goal of lowering their cholesterol, a watershed moment in the history of gene editing that could potentially save millions from cardiovascular disease and heart attacks, MIT Technology Review reports.
Continue Reading![](https://s0.storage.snapzu.com/favicons/f/u/t/u/futurism.com.png)
Join the Discussion